LIXTW
Lixte Biotechnology Holdings, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Geordan G. Pursglove
IPO Date
2020-11-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Lixte Biotechnology Holdings, Inc.
CEO
Geordan G. Pursglove
IPO Date
2020-11-27
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 10,000 |
| $5.88 |
| 13 Dec 2022 | FORMAN ERIC | Vice President and COO | P-Purchase | Acquired | 1,112 | $0.63 |
| 23 Nov 2022 | FORMAN ERIC | Vice President and COO | P-Purchase | Acquired | 2,484 | $0.56 |
| 23 Nov 2022 | FORMAN ERIC | Vice President and COO | P-Purchase | Acquired | 1,457 | $0.56 |
| 21 Nov 2022 | FORMAN ERIC | Vice President and COO | P-Purchase | Acquired | 6,059 | $0.56 |
| 21 Nov 2022 | FORMAN ERIC | Vice President and COO | P-Purchase | Acquired | 2,500 | $0.56 |
| 21 Nov 2022 | FORMAN ERIC | Vice President and COO | P-Purchase | Acquired | 7,648 | $0.57 |
| 21 Nov 2022 | FORMAN ERIC | Vice President and COO | P-Purchase | Acquired | 4,852 | $0.54 |
| 9 Nov 2022 | WEINGARTEN ROBERT N | Vice President and CFO | A-Award | Acquired | 200,000 | $0.00 |